Common Stock, Shares, Outstanding of BIOCEPT INC from 31 Dec 2013 to 30 Jun 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BIOCEPT INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Jun 2023.
  • BIOCEPT INC Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2023 was 2,407,381, a 86% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BIOCEPT INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 2,407,381 -14,515,487 -86% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 17,787,185 +937,024 +5.6% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 568,994 -16,280,811 -97% 31 Dec 2022 10-Q 14 Aug 2023 2023 Q2
Q3 2022 17,058,770 +389,833 +2.3% 30 Sep 2022 10-Q/A 17 Apr 2023 2022 Q3
Q2 2022 16,922,868 +2,612,262 +18% 30 Jun 2022 10-Q 10 Nov 2022 2022 Q2
Q1 2022 16,850,161 +3,447,599 +26% 31 Mar 2022 10-Q 23 May 2022 2022 Q1
Q4 2021 16,849,805 +3,452,764 +26% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 16,668,937 +3,272,367 +24% 30 Sep 2021 10-Q/A 15 Feb 2022 2021 Q3
Q2 2021 14,310,606 -116,902,631 -89% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 13,402,562 -95,304,830 -88% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 13,397,041 +7,923,193 +145% 31 Dec 2020 10-K 05 Apr 2022 2021 FY
Q3 2020 13,396,570 -9,621,665 -42% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 131,213,237 +108,195,002 +470% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 108,707,392 +89,839,928 +476% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 5,473,848 +844,674 +18% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 23,018,235 +19,081,009 +485% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 23,018,235 +20,736,069 +909% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 18,867,464 -49,170,885 -72% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 4,629,174 +3,447,995 +292% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 3,937,226 -26,321,517 -87% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 2,282,166 -26,414,912 -92% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 68,038,349 +41,438,102 +156% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 1,181,179 -16,318,218 -93% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 30,258,743 +21,859,346 +260% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 28,697,078 +3,727,103 +15% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 26,600,247 +6,616,845 +33% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 17,499,397 +10,942,712 +167% 31 Dec 2016 10-K 28 Mar 2018 2017 FY
Q3 2016 8,399,397 -10,367,506 -55% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 24,969,975 +6,323,243 +34% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 19,983,402 +2,085,350 +12% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 6,556,685 +2,107,082 +47% 31 Dec 2015 10-K 28 Mar 2017 2016 FY
Q3 2015 18,766,903 +14,317,300 +322% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 18,646,732 +14,197,129 +319% 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 17,898,052 +13,448,458 +302% 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 4,449,603 +4,264,053 +2298% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 4,449,603 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 4,449,603 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 4,449,594 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 185,550 31 Dec 2013 10-K 11 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.